The personalised healthcare boom

No items found.
​
September 1, 2021

Personalised healthcare is a fairly new term relating to technology that gives individuals effective healthcare based on their own unique attributes. This is distinct from personalised medicine, a well-established area whereby patients receive the right drug or dosage regime that works for them.

Under personalised medicine, a recipient could undergo DNA screening to see what specific form of a disease they have or checks to see whether they have mutations or enzymes that affect whether a drug works for them or not.

Meanwhile, personalised healthcare typically involves interdisciplinary innovations, such as combinations of engineering, physics, chemistry and biotech, offering solutions that 20 years ago would have sounded like science fiction.

For example, treatments now available include using a patient’s cells to grow them a new blood vessel, organ, or customised implant to replace a part of a jawbone. Researchers at Nottingham Trent University have 3D printed realistic organs from scans of cancer patients so doctors can practice surgery to remove tumours from those individual patients.

A Swiss company has developed a way to take skin cells from a patient and then grow them in the lab to create a personalised skin graft, which should give better outcomes than conventional skin grafting.

What also marks out personalised healthcare as an exciting area is a rapid acclimatisation among consumers of the elements that require it to work: the monitoring and storing of health information, known as the “quantified self”.

Millions of people are already willing users of personalised tracking of their health via smartphones and wearables. Fitness watches have maintained their popularity and are becoming more advanced almost with every iteration.

The latest Apple device monitors pulse and oxygen saturation and stores it in the cloud. And the COVID-19 pandemic has driven a boom in people buying thermometers and oximeters.

These developments show a direction of travel towards people being comfortable with devices that monitor them personally. It is not hard to see the ready adoption of devices that also, for example, send that information to their doctor.

The rest of this article is available to download as part of our ‘what’s next for medtech’ whitepaper. Download for free here.

The Latest Thought Leadership pieces in the Content Hub

No items found.
Stay in the Know

The Patent Strategist

Get expert insights and the top patent stories delivered straight to your inbox.

Heading
This is some text inside of a div block.
This is some text inside of a div block.

Latest Insights

Showing 0 of 100
UPC Agreement Is Not EU Law, No Referrals to CJEU
01 September 2025
expert v. Seoul Viosys, UPC_CoA_380/2025 Order of 20 August 2025 (ORD_22147/2025)[1] This order from the UPC Court of Appeal clearly states that the Court of Justice of the EU cannot be asked to...
#
Litigation
​
Unconventional Service: igus v. Whale Technology
29 August 2025
UPC_CFI_318/2025, decision of 5 August 2025 (ORD_34299/2025)[1] In a default judgment issued by the Düsseldorf Local Division of the Unified Patent Court, Whale Technology (Shanghai) Co., Ltd.
#
Litigation
​
A Cloud of Uncertainty: Implications of G 1/23 for Software Companies
29 July 2025
On 2 July 2025, the Enlarged Board of Appeal of the European Patent Office (EPO) issued its landmark decision in case G 1/23 (Solar Cell Sealing Materials and Solar Cell Module), a ruling that has...
#
Consulting
​
Flawed consultation on Standard Essential Patents launched by UK Government
29 July 2025
Earlier this month, the UK Government unveiled its latest consultation on Standard Essential Patents, proposing some "practical steps" which they are considering to "create a more balanced system"...
#
Litigation
​
UPC refuses extension of deadline for review of seizure order after refusal of service
22 July 2025
Sichuan Yuanxing Rubber Co., Ltd. and China Council for the Promotion of International Trade, Automotive Sub Council Order of 14 July 2025 (ORD_26742/2025 [1]) This article follows up on the UPC...
#
Litigation
​
UPC grants ‘in absentia’ permanent injunction on agricultural tool
21 July 2025
Maschio Gaspardo S.p.A. v Spiridonakis Bros GP (UPC_CFI_513/2024 relating to EP1998604) Order of 25 June 2025 (ORD_17812/2025 [1]) This Decision from the Central Division of the Unified Patent Court...
#
Litigation
​
Applying Ocado, the UPC grants a R262 request to access CFI documents
09 July 2025
NJOY Netherlands B.V v Juul Labs International, Inc (UPC_CFI_309/2023) Order issued 9 June 2025 (ORD_27305/2025) [1] The Paris Central Division revoked Juul Lab's patent EP 3 498 115 B1 by decision...
#
Litigation
​
Unified Patent Court: The Impact of Brexit
26 June 2025
The Unified Patent Court (UPC) now has jurisdiction over 18 of the 27 EU states and advertises itself as an EU court but is there any prospect of the UK getting involved in the Unified Patent Court...
#
Consulting
​
Lionra Technologies Ltd. v Cisco Systems GmbH and Cisco Systems, Inc.
25 June 2025
UPC_CFI_58/2024 Following a decision, a successful party has one month to apply for a costs decision (Rule 151). In the relevant case, the main decision (dated 19 February 2025) stated that the...
#
Litigation
​
Provisional Injunction Denied for Small Molecule Kinase Inhibitor
19 June 2025
Zentiva Portugal, LDA v. Boehringer Ingelheim International GMBH (UPC_CFI_41/2025 relating to EP1830843) Court of First Instance Order dated 8 May 2025 ORD_18599/2025 [1] Summary The Application for...
#
Litigation
​
Avoiding Added Matter Pitfalls: Mastering Amendments Before the EPO
17 June 2025
"Added matter" objections are a common and often frustrating hurdle in European patent prosecution. The European Patent Office (EPO) takes a particularly strict stance on claim amendments, especially...
#
Patenting
​
The UPC two years on: Withdrawals of actions becoming prominent
09 June 2025
The Unified Patent Court has now been running for two years. To mark the occasion, we have looked at the cases and the decisions over the past two years, and share our thoughts on the current state...
#
Litigation
​
INTA 2026 Essentials: Where to stay, what to see and what to do
03 June 2025
Discover the INTA 2026 Essentials! This comprehensive guide will help you navigate your stay, showcasing the best accommodations, must-see attractions, and exciting activities to enjoy during your visit.
#
Patenting
​
Building a Resilient Quantum Patent Portfolio: Winning the Race to File First
29 May 2025
A key question for those working in a fast-paced and complex industry such as quantum technology is when to patent any technological developments.
#
Consulting
​
AI and Bitstreams at the Core of China’s Patent Update
28 May 2025
On April 30, 2025, the China National Intellectual Property Administration (CNIPA) released a draft amendment of the Patent Examination Guidelines (for public comment), proposing further revisions to...
#
Patenting
​